Epigenetic Analysis Outlines Factors Predicting HMA Response in MDS, AML
Researchers sought to determine what factors may help predict what patients with MDS or AML would respond to treatment with azacitidine.
All articles by Jonathan Goodman, MPhil
Patients With Multiple Myeloma Receiving Belantamab Mafodotin Can Recover From Ocular Events
Researchers sought to determine whether patients with RRMM with ocular events induced by belantamab mafodotin would recover without discontinuing treatment.
HFE Mutations Have Unknown Impact on Outcomes for Patients With Myelodysplastic Syndromes
Researchers evaluated the rates and significance of HFE variants in a population of patients with MDS.
Whole-Genome Sequencing Shows Promise for Risk Stratification in AML, MDS
Researchers sought to determine whether whole-genome sequencing may be a better risk stratification tool compared with conventional cytogenetic analysis.
Hypomagnesemia at Time of Transplant Associated With Worse Survival in Patients With DLBCL
Researchers sought to determine whether hypomagnesemia increases the risk of failure for autologous hematopoietic stem cell transplantation in patients with DLBCL.
Rivaroxaban May Be Clinically Superior to LMWH in Patients With Cancer-Associated Thrombosis
Researchers sought to determine whether rivaroxaban may be superior to low-molecular-weight heparin for reducing all-cause mortality.
Next-Generation Sequencing May Help Identify Infection in Hematologic Malignancies
Researchers reviewed patient samples to determine whether NGS of cell-free DNA may help in treatment decision-making for patients with hematologic malignancies who may have an infection.
Fractionated Gemtuzumab Ozogamicin Not Linked With Increased VOD/SOS Risk in Acute Myeloid Leukemia
Among patients with de novo AML, fractionated-dose gemtuzumab ozogamicin does not appear to increase the risk of hepatic VOD/SOS after HSCT.
Study Confirms Stem Cell Transplantation Increases Mortality Risk From COVID-19
Patients who have undergone either autologous or allogeneic hematopoietic stem cell transplantation (HSCT) are at high risk for mortality in the event of a COVID-19 diagnosis.
Survey Reveals Varied Treatment of VTE in Pediatric Acute Lymphocytic Leukemia
A team of researchers identified a lack of standardized practices for treating venous thromboembolism among pediatric patients with acute lymphocytic leukemia.
- Loading...
Loading...
Next post in Hematologic Cancers
Loading... 
Loading...